rewirebio.iobenchmarks
Evidence claim

Relevance of cfMethyl-Seq random-split four-cancer detection to "Select a plasma ctDNA methylation detection workflow"

Use case
Select a plasma ctDNA methylation detection workflow
Assessed by
cfMethyl-Seq random-split four-cancer detection
Relevance
Direct evidence
Endpoint
All-stage cancer-detection sensitivity (95% CI) at a declared specificity for cfMethyl-Seq on a repeated random 25% test split

A repeated-split cross-validated sensitivity/specificity figure at a declared specificity directly measures plasma cfDNA methylation cancer-detection performance, the declared endpoint.

1 reviewed evaluation

Evidence

Source checking verifies the cited claim or transcription. It does not establish independent reproduction.

Evidence table

Inspect claims, sources and review details

Trace each statement to its source and review. A context-only reference supports the record generally; it does not verify an individual field. Source checking does not reproduce an experiment.

One row per statement and cited source. Multiple citations are not independent evaluations. Shared locators are labelled explicitly.

30 evidence rows matching the loaded filters

Claims, original sources and review scope · Release 2026-11-21-c8bea25e5abb
Property and statementOriginal source and locationReview and provenance
Citation locations
2 values
  • source id
    amp-source-cfmethyl
    locator
    See clinical/claims.csv and clinical/sources.md in data/omics/use-case-coverage-amp-20261007/
  • source id
    amp-source-cfmethyl-correction
    locator
    See clinical/claims.csv and clinical/sources.md in data/omics/use-case-coverage-amp-20261007/
Context-only references
cfMethyl-Seq cancer detection primary paper

Original source ↗

amp-source-cfmethyl: See clinical/claims.csv and clinical/sources.md in data/omics/use-case-coverage-amp-20261007/; amp-source-cfmethyl-correction: See clinical/claims.csv and clinical/sources.md in data/omics/use-case-coverage-amp-20261007/

Shared locator for this statement’s cited sources; not a separate locator for each citation.

Version: 2022 version of record, corrected competing-interest disclosure in 2024
Retrieved: 2026-10-07T12:24:42.995810+00:00

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.citation_locators

Source artifact SHA-256: 6b299962d4cb5684ef98e7f765df16eb19c7833eca66fc5b0cbdc6aa9be29eca

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Citation locations
2 values
  • source id
    amp-source-cfmethyl
    locator
    See clinical/claims.csv and clinical/sources.md in data/omics/use-case-coverage-amp-20261007/
  • source id
    amp-source-cfmethyl-correction
    locator
    See clinical/claims.csv and clinical/sources.md in data/omics/use-case-coverage-amp-20261007/
Context-only references
cfMethyl-Seq author correction

Original source ↗

amp-source-cfmethyl: See clinical/claims.csv and clinical/sources.md in data/omics/use-case-coverage-amp-20261007/; amp-source-cfmethyl-correction: See clinical/claims.csv and clinical/sources.md in data/omics/use-case-coverage-amp-20261007/

Shared locator for this statement’s cited sources; not a separate locator for each citation.

Version: 2024-05-01 correction
Retrieved: 2026-10-07T12:25:50.907376+00:00

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.citation_locators

Source artifact SHA-256: d573fa7f3190d227d1c3eed9a98619032f1fb8e787f37d1e65843e5d4700ef48

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Constraints
2 values
  • Inspect every linked evaluation's source locator and preserved conflicts before citing a result.
  • Do not combine this mapping's evaluations with any other protocol's results.
Context-only references
cfMethyl-Seq cancer detection primary paper

Original source ↗

amp-source-cfmethyl: See clinical/claims.csv and clinical/sources.md in data/omics/use-case-coverage-amp-20261007/; amp-source-cfmethyl-correction: See clinical/claims.csv and clinical/sources.md in data/omics/use-case-coverage-amp-20261007/

Shared locator for this statement’s cited sources; not a separate locator for each citation.

Version: 2022 version of record, corrected competing-interest disclosure in 2024
Retrieved: 2026-10-07T12:24:42.995810+00:00

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.constraints

Source artifact SHA-256: 6b299962d4cb5684ef98e7f765df16eb19c7833eca66fc5b0cbdc6aa9be29eca

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Constraints
2 values
  • Inspect every linked evaluation's source locator and preserved conflicts before citing a result.
  • Do not combine this mapping's evaluations with any other protocol's results.
Context-only references
cfMethyl-Seq author correction

Original source ↗

amp-source-cfmethyl: See clinical/claims.csv and clinical/sources.md in data/omics/use-case-coverage-amp-20261007/; amp-source-cfmethyl-correction: See clinical/claims.csv and clinical/sources.md in data/omics/use-case-coverage-amp-20261007/

Shared locator for this statement’s cited sources; not a separate locator for each citation.

Version: 2024-05-01 correction
Retrieved: 2026-10-07T12:25:50.907376+00:00

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.constraints

Source artifact SHA-256: d573fa7f3190d227d1c3eed9a98619032f1fb8e787f37d1e65843e5d4700ef48

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Endpoint
All-stage cancer-detection sensitivity (95% CI) at a declared specificity for cfMethyl-Seq on a repeated random 25% test split
Context-only references
cfMethyl-Seq cancer detection primary paper

Original source ↗

amp-source-cfmethyl: See clinical/claims.csv and clinical/sources.md in data/omics/use-case-coverage-amp-20261007/; amp-source-cfmethyl-correction: See clinical/claims.csv and clinical/sources.md in data/omics/use-case-coverage-amp-20261007/

Shared locator for this statement’s cited sources; not a separate locator for each citation.

Version: 2022 version of record, corrected competing-interest disclosure in 2024
Retrieved: 2026-10-07T12:24:42.995810+00:00

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.endpoint

Source artifact SHA-256: 6b299962d4cb5684ef98e7f765df16eb19c7833eca66fc5b0cbdc6aa9be29eca

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Endpoint
All-stage cancer-detection sensitivity (95% CI) at a declared specificity for cfMethyl-Seq on a repeated random 25% test split
Context-only references
cfMethyl-Seq author correction

Original source ↗

amp-source-cfmethyl: See clinical/claims.csv and clinical/sources.md in data/omics/use-case-coverage-amp-20261007/; amp-source-cfmethyl-correction: See clinical/claims.csv and clinical/sources.md in data/omics/use-case-coverage-amp-20261007/

Shared locator for this statement’s cited sources; not a separate locator for each citation.

Version: 2024-05-01 correction
Retrieved: 2026-10-07T12:25:50.907376+00:00

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.endpoint

Source artifact SHA-256: d573fa7f3190d227d1c3eed9a98619032f1fb8e787f37d1e65843e5d4700ef48

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Claimed field
links:assessed_by:amp-protocol-cfmethyl-randomsplit-detection
Context-only references
cfMethyl-Seq cancer detection primary paper

Original source ↗

amp-source-cfmethyl: See clinical/claims.csv and clinical/sources.md in data/omics/use-case-coverage-amp-20261007/; amp-source-cfmethyl-correction: See clinical/claims.csv and clinical/sources.md in data/omics/use-case-coverage-amp-20261007/

Shared locator for this statement’s cited sources; not a separate locator for each citation.

Version: 2022 version of record, corrected competing-interest disclosure in 2024
Retrieved: 2026-10-07T12:24:42.995810+00:00

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.field

Source artifact SHA-256: 6b299962d4cb5684ef98e7f765df16eb19c7833eca66fc5b0cbdc6aa9be29eca

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Claimed field
links:assessed_by:amp-protocol-cfmethyl-randomsplit-detection
Context-only references
cfMethyl-Seq author correction

Original source ↗

amp-source-cfmethyl: See clinical/claims.csv and clinical/sources.md in data/omics/use-case-coverage-amp-20261007/; amp-source-cfmethyl-correction: See clinical/claims.csv and clinical/sources.md in data/omics/use-case-coverage-amp-20261007/

Shared locator for this statement’s cited sources; not a separate locator for each citation.

Version: 2024-05-01 correction
Retrieved: 2026-10-07T12:25:50.907376+00:00

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.field

Source artifact SHA-256: d573fa7f3190d227d1c3eed9a98619032f1fb8e787f37d1e65843e5d4700ef48

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Limitations
3 values
  • No foundation-model comparison
  • No prospective screening benefit
  • No independent reproduction
Context-only references
cfMethyl-Seq cancer detection primary paper

Original source ↗

amp-source-cfmethyl: See clinical/claims.csv and clinical/sources.md in data/omics/use-case-coverage-amp-20261007/; amp-source-cfmethyl-correction: See clinical/claims.csv and clinical/sources.md in data/omics/use-case-coverage-amp-20261007/

Shared locator for this statement’s cited sources; not a separate locator for each citation.

Version: 2022 version of record, corrected competing-interest disclosure in 2024
Retrieved: 2026-10-07T12:24:42.995810+00:00

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.limitations

Source artifact SHA-256: 6b299962d4cb5684ef98e7f765df16eb19c7833eca66fc5b0cbdc6aa9be29eca

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Limitations
3 values
  • No foundation-model comparison
  • No prospective screening benefit
  • No independent reproduction
Context-only references
cfMethyl-Seq author correction

Original source ↗

amp-source-cfmethyl: See clinical/claims.csv and clinical/sources.md in data/omics/use-case-coverage-amp-20261007/; amp-source-cfmethyl-correction: See clinical/claims.csv and clinical/sources.md in data/omics/use-case-coverage-amp-20261007/

Shared locator for this statement’s cited sources; not a separate locator for each citation.

Version: 2024-05-01 correction
Retrieved: 2026-10-07T12:25:50.907376+00:00

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.limitations

Source artifact SHA-256: d573fa7f3190d227d1c3eed9a98619032f1fb8e787f37d1e65843e5d4700ef48

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

How to read the evidence

Sources and history

Release 2026-11-21-c8bea25e5abb · Record review: source checked

2 source records and release historyDownload this release (gzip)
Technical metadata and extraction receipts

Stable ID: use-case-mapping-amp-20261007-issue16

field
links:assessed_by:amp-protocol-cfmethyl-randomsplit-detection
value
amp-protocol-cfmethyl-randomsplit-detection
relevance
direct
endpoint
All-stage cancer-detection sensitivity (95% CI) at a declared specificity for cfMethyl-Seq on a repeated random 25% test split
rationale
A repeated-split cross-validated sensitivity/specificity figure at a declared specificity directly measures plasma cfDNA methylation cancer-detection performance, the declared endpoint.
constraints
Inspect every linked evaluation's source locator and preserved conflicts before citing a result.; Do not combine this mapping's evaluations with any other protocol's results.
limitations
No foundation-model comparison; No prospective screening benefit; No independent reproduction
revision
1
reason
Add Codex-checked primary-source protocol evidence from the bounded AMP intake (rewire.it#365).
citation locators
source id: amp-source-cfmethyl; locator: See clinical/claims.csv and clinical/sources.md in data/omics/use-case-coverage-amp-20261007/; source id: amp-source-cfmethyl-correction; locator: See clinical/claims.csv and clinical/sources.md in data/omics/use-case-coverage-amp-20261007/
source locator
amp-source-cfmethyl: See clinical/claims.csv and clinical/sources.md in data/omics/use-case-coverage-amp-20261007/; amp-source-cfmethyl-correction: See clinical/claims.csv and clinical/sources.md in data/omics/use-case-coverage-amp-20261007/
review
method: automated-source-review; reviewer: codex; claude-sonnet; reviewer note: Claude Sonnet AMP-integration worker, bounded transcription of Codex-checked primary values; independently reviewed by Codex (workbench/amp-supervision/primary-review.md, integration-review-corrections.md); reviewed at: 2026-10-07T13:38:59Z; note: Bounded primary-source transcription, independently Codex-checked. No new model execution, independent experimental reproduction, qualified human scientific review or clinical validation.
reviewed evaluations
amp-eval-cfmethyl-allstage-sensitivity
pins
record id: amp-eval-cfmethyl-allstage-sensitivity; fields: status; links; attributes.origin; attributes.comparison; sha256: b169760fcb27ba474469407d590f9316d8685df23fb4a4284fa728ba308192d7; record id: amp-protocol-cfmethyl-randomsplit-detection; fields: status; name; description; facets; source_ids; links; attributes; sha256: aa59aff860d0c5e13ccc7ed06b28a880ae42aa01a780e950aa2746239122ea64; record id: amp-result-cfmethyl-allstage-sensitivity; fields: status; attributes.metric; attributes.metric_qualifier; attributes.printed_value; attributes.numeric_value; sha256: ccfdcb0f53de76382cba4ab2123d1cd7f742a52ed83bf21bd404d955d5ba910c; record id: amp-source-cfmethyl; fields: status; attributes.artifact_sha256; sha256: 59afebd3354186794d6cc1599490e86d35ff81a9de3e9131599ed12cd17998a1; record id: amp-source-cfmethyl-correction; fields: status; attributes.artifact_sha256; sha256: 0037edee085d6913f3a41a04bdb3f717e24684f27dd7c2bbe20015ba892e1983; record id: use-case-plasma-ctdna-methylation; fields: status; name; description; facets; attributes.question; attributes.decision; attributes.inputs; attributes.output; attributes.exclusions; attributes.setting; attributes.clinical_scope; attributes.intended_users; sha256: 4d9542463e1400d5d9701c7f52859a23e4c78804cbda1477663445f945e22429
Related records

Suggest a correction